Veru Inc (VERU)
1.63
-0.01
(-0.61%)
USD |
NASDAQ |
May 03, 16:00
1.62
-0.01
(-0.61%)
After-Hours: 20:00
Veru Max Drawdown (5Y): 98.44% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.44% |
March 31, 2024 | 98.44% |
February 29, 2024 | 98.44% |
January 31, 2024 | 98.44% |
December 31, 2023 | 97.17% |
November 30, 2023 | 96.98% |
October 31, 2023 | 96.98% |
September 30, 2023 | 96.98% |
August 31, 2023 | 95.90% |
July 31, 2023 | 95.90% |
June 30, 2023 | 95.90% |
May 31, 2023 | 95.84% |
April 30, 2023 | 95.79% |
March 31, 2023 | 95.12% |
February 28, 2023 | 85.41% |
January 31, 2023 | 85.41% |
December 31, 2022 | 85.41% |
November 30, 2022 | 87.38% |
October 31, 2022 | 87.79% |
September 30, 2022 | 89.94% |
August 31, 2022 | 89.94% |
July 31, 2022 | 89.94% |
June 30, 2022 | 89.94% |
May 31, 2022 | 89.94% |
April 30, 2022 | 89.94% |
Date | Value |
---|---|
March 31, 2022 | 89.94% |
February 28, 2022 | 89.94% |
January 31, 2022 | 90.56% |
December 31, 2021 | 90.56% |
November 30, 2021 | 90.56% |
October 31, 2021 | 90.56% |
September 30, 2021 | 90.66% |
August 31, 2021 | 91.38% |
July 31, 2021 | 91.58% |
June 30, 2021 | 91.58% |
May 31, 2021 | 91.58% |
April 30, 2021 | 91.58% |
March 31, 2021 | 91.58% |
February 28, 2021 | 91.58% |
January 31, 2021 | 91.58% |
December 31, 2020 | 91.58% |
November 30, 2020 | 91.58% |
October 31, 2020 | 91.58% |
September 30, 2020 | 91.58% |
August 31, 2020 | 91.58% |
July 31, 2020 | 91.58% |
June 30, 2020 | 91.58% |
May 31, 2020 | 91.58% |
April 30, 2020 | 91.58% |
March 31, 2020 | 91.58% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
85.41%
Minimum
Dec 2022
98.44%
Maximum
Jan 2024
92.07%
Average
91.58%
Median
May 2019
Max Drawdown (5Y) Benchmarks
EyePoint Pharmaceuticals Inc | 93.95% |
Regeneron Pharmaceuticals Inc | 53.84% |
Bio-Path Holdings Inc | 99.48% |
Aileron Therapeutics Inc | 99.06% |
Scholar Rock Holding Corp | 93.15% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 2.667 |
Beta (5Y) | -0.4754 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 147.0% |
Historical Sharpe Ratio (5Y) | -0.0179 |
Historical Sortino (5Y) | -0.0501 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.27% |